Audentes Therapeutics, Inc. Comprehensive Income
Audentes Therapeutics, Inc. reported Comprehensive Income of -$45.74 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2019-11-07
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was -$45.74M.
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-06-30 was -$44.60M.
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-03-31 was -$49.26M.
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-12-31 was -$35.69M.
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$128.88M.
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$90.29M.
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$59.69M.
- Audentes Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was -$26.46M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | -$45.74M 10-Q · filed 2019-11-07 | -$90.35M derived: sum of 2 quarters · filed 2019-11-07 | -$139.61M 10-Q · filed 2019-11-07 | -$175.29M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-06-30 | -$44.60M 10-Q · filed 2019-08-07 | -$93.87M 10-Q · filed 2019-08-07 | -$129.55M derived: sum of 3 quarters · filed 2019-08-07 | -$165.85M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-03-31 | -$49.26M 10-Q · filed 2019-05-08 | -$84.95M derived: sum of 2 quarters · filed 2019-05-08 | -$121.24M derived: sum of 3 quarters · filed 2019-11-07 | -$152.56M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-12-31 | -$35.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$71.98M derived: sum of 2 quarters · filed 2019-11-07 | -$103.30M derived: sum of 3 quarters · filed 2019-11-07 | -$128.88M 10-K · filed 2019-03-01 | |
| 2018-09-30 | -$36.30M 10-Q · filed 2019-11-07 | -$67.61M derived: sum of 2 quarters · filed 2019-11-07 | -$93.20M 10-Q · filed 2019-11-07 | -$117.63M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | -$31.32M 10-Q · filed 2019-08-07 | -$56.90M 10-Q · filed 2019-08-07 | -$81.34M derived: sum of 3 quarters · filed 2019-08-07 | -$106.33M derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | -$25.59M 10-Q · filed 2019-05-08 | -$50.02M derived: sum of 2 quarters · filed 2019-05-08 | -$75.01M derived: sum of 3 quarters · filed 2019-05-08 | -$97.76M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$24.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$49.43M derived: sum of 2 quarters · filed 2019-03-01 | -$72.17M derived: sum of 3 quarters · filed 2019-03-01 | -$90.29M 10-K · filed 2019-03-01 | |
| 2017-09-30 | -$24.99M 10-Q · filed 2018-11-07 | -$47.74M derived: sum of 2 quarters · filed 2018-11-07 | -$65.85M 10-Q · filed 2018-11-07 | -$85.56M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$22.75M 10-Q · filed 2018-08-07 | -$40.86M 10-Q · filed 2018-08-07 | -$60.57M derived: sum of 3 quarters · filed 2019-03-01 | -$75.94M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | -$18.11M 10-Q · filed 2018-05-10 | -$37.82M derived: sum of 2 quarters · filed 2019-03-01 | -$53.19M derived: sum of 3 quarters · filed 2019-03-01 | -$67.35M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$19.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$35.08M derived: sum of 2 quarters · filed 2019-03-01 | -$49.24M derived: sum of 3 quarters · filed 2019-03-01 | -$59.69M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$15.37M 10-Q · filed 2017-11-14 | -$29.53M derived: sum of 2 quarters · filed 2017-11-14 | -$39.98M 10-Q · filed 2017-11-14 | -$49.95M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | -$14.16M 10-Q · filed 2017-08-10 | -$14.16M 10-Q · filed 2016-09-01 | -$24.61M 10-Q · filed 2017-08-10 | -$34.57M derived: sum of 3 quarters · filed 2018-03-09 | -$41.59M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | -$10.45M 10-Q · filed 2017-05-11 | -$20.41M derived: sum of 2 quarters · filed 2018-03-09 | -$27.43M derived: sum of 3 quarters · filed 2018-03-09 | -$32.86M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | -$9.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$16.98M derived: sum of 2 quarters · filed 2018-03-09 | -$22.41M derived: sum of 3 quarters · filed 2018-03-09 | -$26.46M 10-K · filed 2018-03-09 | |
| 2015-09-30 | -$7.02M 10-Q · filed 2016-11-10 | -$12.44M derived: sum of 2 quarters · filed 2016-11-10 | -$16.49M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$5.43M 10-Q · filed 2016-09-01 | -$9.48M 10-Q · filed 2016-09-01 | |||
| 2014-12-31 | -$10.83M 10-K · filed 2017-03-13 |